Doxee (DOX) H1 2024 earnings summary

Executive summary

• Revenue for H1 2024 reached €12.5 million, up 3.2% year-over-year, driven by expansion in DACH and CEE regions, with value of production at €14.0 million.

• EBITDA turned positive at €0.5 million, reflecting improved internal efficiency and cost reductions compared to a loss of €0.5 million in H1 2023.

• Net loss narrowed to €2.4 million from €3.2 million in H1 2023, mainly due to increased amortization.

• Net financial debt reduced to €17.0 million from €21.6 million at FY 2023, supported by a €5.8 million capital increase used to repay loans and payables.

• Strategic focus on integrating Infinica GmbH (now Doxee AT), launching the unified Doxee PlatformⓇ, and renewing major multi-year contracts with a 98% net retention rate.

Financial highlights

• Revenues: €12.5 million (+3.2% YoY); Value of Production: €14.0 million.

• EBITDA: €0.5 million (vs. -€0.5 million in H1 2023); EBIT: -€2.0 million (vs. -€2.6 million).

• Net income: -€2.4 million (vs. -€3.2 million YoY); Net working capital: -€3.3 million.

• Contribution margin increased 17.2% to €7.5 million, reflecting lower internal staff and consultancy costs.

• Group shareholders' equity increased to €10.0 million, up from €6.5 million at year-end 2023.

Outlook and guidance

• Focus on sustainable revenue growth, cost actions, and increased ARR and gross margin.

• Continued reduction in R&D and external costs, leveraging platform efficiencies.

• Strengthening sales and pre-sales teams, especially in DACH region.

• Ongoing internationalization and expansion in DACH and CEE markets.

• H2 2024 to emphasize cost containment, Infinica integration, and enterprise market repositioning.